Media Registration Opens for Human Gene-Editing Summit to Be Held Dec. 1-3 in Washington, D.C.


Powerful new human gene-editing technologies, such as CRISPR-Cas9, hold great promise for advancing science and treating disease.  These technologies also raise concerns and present complex challenges, particularly because of their potential to be used to make genetic changes that could be passed on to future generations, thereby modifying the human germline.


The U.S. National Academy of Sciences, U.S. National Academy of Medicine, Chinese Academy of Sciences, and the Royal Society - the science academy of the UK - will co-host a three-day international summit where global experts will discuss the scientific, ethical, and governance issues associated with these new and emerging human gene-editing technologies. 


Topics to be examined over the course of the summit include:


-       the historical context for human gene-editing research;

-       the science of human gene-editing technologies;

-       possible applications for the treatment of disease; 

-       implications of potential germline modification;

-       societal implications, including issues of equity, access, and race;  

-       international perspectives; and

-       institutional, national, and international oversight.


Follow the conversation on Twitter using #GeneEditSummit.



The summit will take place from 0800 to 1900 EST on Dec. 1-2 and from  0815  to 1500 EST on Dec. 3 at the National Academy of Sciences building; 2101 Constitution Ave., Washington, D.C. Those who cannot attend may watch a live webcast of the summit at


Seating is limited; reporters who wish to attend MUST REGISTER IN ADVANCE.   For a draft agenda or more information, visit or contact the U.S. Academies' Office of News and Public Information; tel. +1-202-334-2138 or e-mail


The summit is part of a broader initiative on human gene editing launched by the National Academy of Sciences and National Academy of Medicine.